Perfusion MR imaging of extracranial tumor angiogenesis
- PMID: 15057172
- DOI: 10.1097/00002142-200402000-00005
Perfusion MR imaging of extracranial tumor angiogenesis
Erratum in
- Top Magn Reson Imaging. 2004 Apr;15(2):67
Abstract
Dynamic contrast-enhanced MRI (DCE-MRI) using small molecular weight gadolinium chelates enables noninvasive imaging characterization of tissue vascularity. Depending on the technique used, data reflecting tissue perfusion (blood flow, blood volume, mean transit time), microvessel permeability surface area product, and extracellular leakage space can be obtained. Insights into these physiological processes can be obtained from inspection of kinetic enhancement curves or by the application of complex compartmental modeling techniques. Combining morphologic and kinetic features can increase the accuracy of clinical diagnoses. Potential clinical applications include screening for malignant disease, lesion characterization, monitoring lesion response to treatment, and assessment of residual disease. Newer applications include prognostication, pharmacodynamic assessments of antivascular anticancer drugs, and predicting efficacy of treatment. For dynamic MRI to enter into widespread clinical practice, it will be necessary to develop standardized approaches to measurement and robust analysis approaches.
Similar articles
-
Dynamic contrast enhanced MRI in prostate cancer.Eur J Radiol. 2007 Sep;63(3):335-50. doi: 10.1016/j.ejrad.2007.06.028. Epub 2007 Aug 8. Eur J Radiol. 2007. PMID: 17689907 Review.
-
MRI for assessing antivascular cancer treatments.Br J Radiol. 2003;76 Spec No 1:S60-80. doi: 10.1259/bjr/15334380. Br J Radiol. 2003. PMID: 15456715 Review.
-
Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition.Invest Radiol. 2006 Mar;41(3):325-31. doi: 10.1097/01.rli.0000186565.21375.88. Invest Radiol. 2006. PMID: 16481916 Review.
-
[Magnetic resonance imaging of angiogenesis in tumors].J Radiol. 2007 Mar;88(3 Pt 1):331-8. doi: 10.1016/s0221-0363(07)89829-5. J Radiol. 2007. PMID: 17457264 Review. French.
-
Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging.Abdom Imaging. 2005 May-Jun;30(3):324-41. doi: 10.1007/s00261-004-0265-5. Abdom Imaging. 2005. PMID: 15688112 Review.
Cited by
-
Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.PLoS One. 2017 Jan 6;12(1):e0169323. doi: 10.1371/journal.pone.0169323. eCollection 2017. PLoS One. 2017. PMID: 28060884 Free PMC article.
-
The clinical value of dynamic contrast-enhanced MRI in differential diagnosis of malignant and benign ovarian lesions.Tumour Biol. 2015 Jul;36(7):5515-22. doi: 10.1007/s13277-015-3219-3. Epub 2015 Feb 28. Tumour Biol. 2015. PMID: 25724182
-
Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.Eur Radiol. 2012 Apr;22(4):738-45. doi: 10.1007/s00330-011-2329-6. Epub 2011 Nov 23. Eur Radiol. 2012. PMID: 22105841
-
Clinical biomarkers of angiogenesis inhibition.Cancer Metastasis Rev. 2008 Sep;27(3):415-34. doi: 10.1007/s10555-008-9143-x. Cancer Metastasis Rev. 2008. PMID: 18414993 Free PMC article. Review.
-
Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?Br J Radiol. 2015 Sep;88(1053):20150099. doi: 10.1259/bjr.20150099. Epub 2015 Jun 17. Br J Radiol. 2015. PMID: 26083260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical